Century Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Century Therapeutics stock have an average target of 4.25, with a low estimate of 2.00 and a high estimate of 6.00. The average target predicts an increase of 93.18% from the current stock price of 2.20.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$2.00	$4.25	$5.00	$6.00
Change	-9.09%	+93.18%	+127.27%	+172.73%

Analyst Ratings

The average analyst rating for Century Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	4	4	4	4	4	2
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell S. Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $2 → $5	Strong Buy	Maintains	$2 → $5	+127.27%	Apr 21, 2026
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Maintains $2 → $4	Buy	Maintains	$2 → $4	+81.82%	Jan 20, 2026
Daina Graybosch Leerink Partners	Leerink Partners	Buy → Hold Downgrades $7 → $2	Buy → Hold	Downgrades	$7 → $2	-9.09%	Nov 17, 2025
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $7 → $6	Strong Buy	Maintains	$7 → $6	+172.73%	May 16, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $5 → $2	Strong Buy	Maintains	$5 → $2	-9.09%	Apr 3, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 109.16M

Revenue Next Year

n/a

EPS This Year

-0.55

from -0.11

EPS Next Year

-0.48

from -0.55

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	5.20M	2.24M	6.59M	109.16M	-	-
Revenue Growth	-	-	-57.01%	194.81%	1,556.76%	-	-
EPS	-2.96	-2.27	-2.30	-1.61	-0.11	-0.55	-0.48
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.41	-0.35
Avg	-0.55	-0.48
Low	-0.74	-0.55

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.